Boehringer Ingelheim a

New potential gastrointestinal and lung cancer therapies from Boehringer Ingelheim’s innovative oncology pipeline will be combined with the patient-driven drug-development capabilities at MD Anderson

• The Center will initially investigate KRAS pathway inhibitors and a TRAILR2 antibody from Boehringer Ingelheim’s cancer research

INGELHEIM, Germany -- (BUSINESS WIRE) --

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for various types of cancers, including gastrointestinal and lung cancers. The establishment of a joint Virtual Research and Development Center will enable effective data sharing and analysis between the organizations.

The partnership is built on a flexible framework, allowing for projects to enter at different stages (research, development and/or clinical stage) over several years. It further combines the unique patient-driven drug-development capabilities of MD Anderson’s Therapeutics Discovery division with the innovative pipeline of novel medicines from Boehringer Ingelheim.

MD Anderson’s Therapeutics Discovery division is a multidisciplinary team of clinicians and researchers focused on advancing the next generation of cancer therapies. As part of the division, the TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology) platform conducts cutting-edge translational research to better understand how new medicines work and which patients will see most benefit.

"We could not have chosen a better partner with all its research, translational and clinical expertise in lung and gastrointestinal cancers. Together, we hope to transform the treatment landscape for these diseases by tackling their root causes and drivers, that have so far remained elusive, exploring new and smart ways of killing cancer cells," said Dr Victoria Zazulina, Corporate Vice President and Global Head of Oncology, Medicine, at Boehringer Ingelheim. "Our innovative oncology pipeline coupled with strong partnerships like this will contribute to unravelling the complexities of these diseases and bringing innovative solutions to people with various types of cancers."

The Virtual Research and Development Center will focus on the development of potential new treatments including:

  • KRAS inhibition concepts, as mutations in the KRAS      gene are common in various cancers, specifically in certain types of lung      and gastrointestinal cancers.

  • a TRAILR2 agonistic antibody, with the potential      to selectively induce cancer cell death (apoptosis).

“Within MD Anderson, we are committed to a singular goal of ending cancer,” said Tim Heffernan, Ph.D., executive director of TRACTION at MD Anderson. “We look forward to working with Boehringer Ingelheim to advance their innovative pipeline of cancer medicines. Our Therapeutics Discovery team is well-poised to conduct impactful translational research, and this partnership will allow us to more rapidly advance much-needed new therapies to patients.”

More than 4.1 million people die from gastrointestinal and lung cancers every year worldwide1, indicating an urgent need for new treatment approaches. Gastrointestinal cancers represent a heterogeneous complex array of diseases, and include oesophageal (throat), gastric (stomach), liver, pancreatic, and colorectal cancers. In 2018, lung cancer caused more than 1.7 million deaths1. There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).


相关推荐
新闻聚焦
猜你喜欢
热门推荐
  • 中国新闻传媒集团三周年庆典活动在南京

      来自全国各地的嘉宾云集南京,只是为了庆祝中国新闻传媒成立三周年。 今天的盛会,是中国新闻传媒集团向社会汇报三年......

    09-28    来源:意不尽网

    分享
  • 新县绿和公益举行"气候变化警示牌"揭

      意不尽网讯(记者 阮中华) 10月3日上午,新县绿和公益协会志愿者代表与河南省生态文明建设促进会生态文化传播大使、罗......

    10-04    来源:意不尽网

    分享
  • 新中国成立70周年华诞暨中国传媒新闻集

      本网讯(阮中华 张国强 摄影 董万芳) 2019年9月27日,为庆祝新中国成立70周年暨中国新闻传媒集团成立三周年庆典在南京市......

    09-30    来源:意不尽网

    分享
  • 抗美援朝老兵庆祝70周年华诞活动在中国

      中国老兵事业发展中心讯(袁建国) 时间的年轮,记录着奋斗者的足迹,也见证了中华人民共和国日新月异的变化和激荡的......

    10-02    来源:中国老兵事业发展中心

    分享
  • “气候变化警示牌”亮相墨尔本、悉尼

      本网讯(阮中华) 11月18日至26日,受2030计划委托,2030计划气候使者、绿色旅游世界行发起人王晨琛将人类行为导致气候变化......

    11-29    来源:意不尽网

    分享
  • 全球首个“气候受难者纪念碑”落成仪式

      意不尽网讯(梅东霞) 10月28日上午11时,由北京绿十字、河南省生态文明建设促进会千手行动组委会主办,乡宿.郝堂花间驿......

    10-29    来源:意不尽网

    分享
  • “人类行为导致气候变化警示牌“落户罗

      意不尽网讯(杜永友) 10月21日上午,人类行为导致气候变化警示牌揭牌仪式在罗山县涩港高中校园隆重举行,这是迄今为止......

    10-23    来源:意不尽网

    分享
  • 第三届“寻找最美海外中国游客”在徐霞

      意不尽网讯(阮中华) 10月19日下午,浙江省宁海县图书馆内座无虚席、气氛热烈,第三届寻找最美海外中国游客颁奖暨当代......

    10-21    来源:意不尽网

    分享
  • “人类行为导致气候变化警示碑”揭碑仪

      意不尽网讯(文:杜永友;诗:白露;摄影:李绍清、喻刚、高振林) 囯庆70周年即将到来之际,9月30日下午3点,艳阳高照......

    10-01    来源:意不尽网

    分享
  • ufc深圳站即将展示“中国力量”——“陕

      ufc格斗之夜深圳站将于8月31日开打,张伟丽、李景亮领衔中国力量齐出战使得本次比赛备受中国搏击迷关注。其实,在三秦大......

    08-19    来源:意不尽网

    分享
返回列表
Ctrl+D 将本页面保存为书签,全面了解最新资讯,方便快捷。